LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 151

Search options

  1. Article ; Online: Intrinsic RNA Targeting Triggers Indiscriminate DNase Activity of CRISPR-Cas12a.

    Zhang, Jiongyu / Li, Ziyue / Guo, Chong / Guan, Xin / Avery, Lori / Banach, David / Liu, Changchun

    Angewandte Chemie (International ed. in English)

    2024  Volume 63, Issue 20, Page(s) e202403123

    Abstract: The CRISPR-Cas12a system has emerged as a powerful tool for next-generation nucleic acid-based molecular diagnostics. However, it has long been believed to be effective only on DNA targets. Here, we investigate the intrinsic RNA-enabled trans-cleavage ... ...

    Abstract The CRISPR-Cas12a system has emerged as a powerful tool for next-generation nucleic acid-based molecular diagnostics. However, it has long been believed to be effective only on DNA targets. Here, we investigate the intrinsic RNA-enabled trans-cleavage activity of AsCas12a and LbCas12a and discover that they can be directly activated by full-size RNA targets, although LbCas12a exhibits weaker trans-cleavage activity than AsCas12a on both single-stranded DNA and RNA substrates. Remarkably, we find that the RNA-activated Cas12a possesses higher specificity in recognizing mutated target sequences compared to DNA activation. Based on these findings, we develop the "Universal Nuclease for Identification of Virus Empowered by RNA-Sensing" (UNIVERSE) assay for nucleic acid testing. We incorporate a T7 transcription step into this assay, thereby eliminating the requirement for a protospacer adjacent motif (PAM) sequence in the target. Additionally, we successfully detect multiple PAM-less targets in HIV clinical samples that are undetectable by the conventional Cas12a assay based on double-stranded DNA activation, demonstrating unrestricted target selection with the UNIVERSE assay. We further validate the clinical utility of the UNIVERSE assay by testing both HIV RNA and HPV 16 DNA in clinical samples. We envision that the intrinsic RNA targeting capability may bring a paradigm shift in Cas12a-based nucleic acid detection and further enhance the understanding of CRISPR-Cas biochemistry.
    MeSH term(s) CRISPR-Cas Systems/genetics ; RNA/metabolism ; RNA/chemistry ; RNA/genetics ; CRISPR-Associated Proteins/metabolism ; CRISPR-Associated Proteins/genetics ; Deoxyribonucleases/metabolism ; Endodeoxyribonucleases/metabolism ; Endodeoxyribonucleases/genetics ; Endodeoxyribonucleases/chemistry ; Humans ; Bacterial Proteins
    Chemical Substances RNA (63231-63-0) ; CRISPR-Associated Proteins ; Deoxyribonucleases (EC 3.1.-) ; Cas12a protein (EC 3.1.-) ; Endodeoxyribonucleases (EC 3.1.-) ; Bacterial Proteins
    Language English
    Publishing date 2024-04-10
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2011836-3
    ISSN 1521-3773 ; 1433-7851
    ISSN (online) 1521-3773
    ISSN 1433-7851
    DOI 10.1002/anie.202403123
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The arachidonic acid metabolome reveals elevation of prostaglandin E2 biosynthesis in colorectal cancer.

    Zhang, Cuiping / Hu, Zuojian / Pan, Ziyue / Ji, Zhaodong / Cao, Xinyi / Yu, Hongxiu / Qin, Xue / Guan, Ming

    The Analyst

    2024  Volume 149, Issue 6, Page(s) 1907–1920

    Abstract: Arachidonic acid metabolites are a family of bioactive lipids derived from membrane phospholipids. They are involved in cancer progression, but arachidonic acid metabolite profiles and their related biosynthetic pathways remain uncertain in colorectal ... ...

    Abstract Arachidonic acid metabolites are a family of bioactive lipids derived from membrane phospholipids. They are involved in cancer progression, but arachidonic acid metabolite profiles and their related biosynthetic pathways remain uncertain in colorectal cancer (CRC). To compare the arachidonic acid metabolite profiles between CRC patients and healthy controls, quantification was performed using a liquid chromatography-mass spectrometry-based analysis of serum and tissue samples. Metabolomics analysis delineated the distinct oxidized lipids in CRC patients and healthy controls. Prostaglandin (PGE2)-derived metabolites were increased, suggesting that the PGE2 biosynthetic pathway was upregulated in CRC. The qRT-PCR and immunohistochemistry analyses showed that the expression level of PGE2 synthases, the key protein of PGE2 biosynthesis, was upregulated in CRC and positively correlated with the CD68+ macrophage density and CRC development. Our study indicates that the PGE2 biosynthetic pathway is associated with macrophage infiltration and progression of CRC tumors.
    MeSH term(s) Humans ; Dinoprostone/metabolism ; Arachidonic Acid ; Metabolome ; Metabolomics ; Colorectal Neoplasms/metabolism
    Chemical Substances Dinoprostone (K7Q1JQR04M) ; Arachidonic Acid (27YG812J1I)
    Language English
    Publishing date 2024-03-11
    Publishing country England
    Document type Journal Article
    ZDB-ID 210747-8
    ISSN 1364-5528 ; 0003-2654
    ISSN (online) 1364-5528
    ISSN 0003-2654
    DOI 10.1039/d3an01723k
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Butyrate promotes C2C12 myoblast proliferation by activating ERK/MAPK pathway.

    Guan, Li / Cao, Ziyi / Pan, Ziyue / Zhao, Chao / Xue, Mengjuan / Yang, Fan / Chen, Jie

    Molecular omics

    2023  Volume 19, Issue 7, Page(s) 552–559

    Abstract: Sarcopenia has garnered considerable interest in recent years as ageing-associated diseases constitute a significant worldwide public health burden. Nutritional supplements have received much attention as potential tools for managing sarcopenia. However, ...

    Abstract Sarcopenia has garnered considerable interest in recent years as ageing-associated diseases constitute a significant worldwide public health burden. Nutritional supplements have received much attention as potential tools for managing sarcopenia. However, the specific nutrients responsible are still under-investigated. In the current study, we first determined the levels of short chain fatty acids (SCFAs) and intestinal flora in the feces of elderly sarcopenia subjects and elderly healthy individuals by ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS). Then cell viability detection, flow cytometry and transcriptome analysis were adopted to experimentally evaluate the effect and the underlying mechanism of SCFA on C2C12 cells proliferation
    Language English
    Publishing date 2023-08-14
    Publishing country England
    Document type Journal Article
    ISSN 2515-4184
    ISSN (online) 2515-4184
    DOI 10.1039/d2mo00256f
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A highly sensitive Lock-Cas12a biosensor for detection and imaging of miRNA-21 in breast cancer cells.

    Peng, Jiawei / Liu, Ting / Guan, Liwen / Xu, Ziyue / Xiong, Ting / Zhang, Yu / Song, Jiaxin / Liu, Xuexia / Yang, Yifei / Hao, Xian

    Talanta

    2024  Volume 273, Page(s) 125938

    Abstract: The expression levels of microRNA (miRNA) vary significantly in correlation with the occurrence and progression of cancer, making them valuable biomarkers for cancer diagnosis. However, their quantitative detection faces challenges due to the high ... ...

    Abstract The expression levels of microRNA (miRNA) vary significantly in correlation with the occurrence and progression of cancer, making them valuable biomarkers for cancer diagnosis. However, their quantitative detection faces challenges due to the high sequence homology, low abundance and small size. In this work, we established a strand displacement amplification (SDA) approach based on miRNA-triggered structural "Lock" nucleic acid ("Lock" DNA), coupled with the CRISPR/Cas12a system, for detecting miRNA-21 in breast cancer cells. The "Lock" DNA freed the CRISPR-derived RNA (crRNA) from the dependence on the target sequence and greatly facilitated the extended detection of different miRNAs. Moreover, the CRISPR/Cas12a system provided excellent amplification ability and specificity. The designed biosensor achieved high sensitivity detection of miRNA-21 with a limit of detection (LOD) of 28.8 aM. In particular, the biosensor could distinguish breast cancer cells from other cancer cells through intracellular imaging. With its straightforward sequence design and ease of use, the Lock-Cas12a biosensor offers significant advantages for cell imaging and early clinical diagnosis.
    MeSH term(s) MicroRNAs/genetics ; CRISPR-Cas Systems ; Diagnostic Imaging ; Limit of Detection ; Nucleic Acids ; Biosensing Techniques ; Neoplasms
    Chemical Substances MicroRNAs ; Nucleic Acids
    Language English
    Publishing date 2024-03-16
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1500969-5
    ISSN 1873-3573 ; 0039-9140
    ISSN (online) 1873-3573
    ISSN 0039-9140
    DOI 10.1016/j.talanta.2024.125938
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma.

    Gao, Jianjun / Wang, Jiangang / Guan, Canghai / Shi, Wujiang / Dong, Qingfu / Sheng, Jialin / Zou, Xinlei / Xu, Zhaoqiang / Ge, Yifei / Huang, Ziyue / Li, Jiehan / Bao, Haolin / Xu, Yi / Cui, Yunfu / Xu, Xiaoxue / Zhong, Xiangyu

    Journal of Cancer

    2024  Volume 15, Issue 8, Page(s) 2214–2228

    Abstract: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a notably poor prognosis. A large number of patients with PDAC develop metastases before they are diagnosed with metastatic pancreatic cancer (mPDAC). For mPDAC, FOLFIRINOX or ... ...

    Abstract Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a notably poor prognosis. A large number of patients with PDAC develop metastases before they are diagnosed with metastatic pancreatic cancer (mPDAC). For mPDAC, FOLFIRINOX or gemcitabine plus nab-paclitaxel are the current first-line treatments. It is important to note, however, that many patients will fail chemotherapy because of drug resistance. ​Heterogeneous tumors and complex tumor microenvironments are key factors. As a result, clinical researchers are exploring a variety of alternative treatment modalities. Current understanding of the molecular signature and immune landscape of PDAC has motivated the emergence of different targeted and immune-based therapeutic approaches, some of which have shown promising results. The purpose of this review is to discuss the new targets and new drugs for mPDAC in terms of specific pathogenic factors such as metabolic vulnerability, DNA damage repair system, tumor microenvironment and immune system, in order to identify potential vulnerabilities in mPDAC patients and hopefully improve the prognosis of mPDAC patients.
    Language English
    Publishing date 2024-02-25
    Publishing country Australia
    Document type Journal Article ; Review
    ZDB-ID 2573318-7
    ISSN 1837-9664
    ISSN 1837-9664
    DOI 10.7150/jca.89788
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Exosomal miRNAs in the microenvironment of pancreatic cancer.

    Zou, Xinlei / Huang, Ziyue / Guan, Canghai / Shi, Wujiang / Gao, Jianjun / Wang, Jiangang / Cui, Yunfu / Wang, Mei / Xu, Yi / Zhong, Xiangyu

    Clinica chimica acta; international journal of clinical chemistry

    2023  Volume 544, Page(s) 117360

    Abstract: Pancreatic cancer (PC) is highly aggressive having an extremely poor prognosis. The tumor microenvironment (TME) of PC is complex and heterogeneous. Various cellular components in the microenvironment are capable of secreting different active substances ... ...

    Abstract Pancreatic cancer (PC) is highly aggressive having an extremely poor prognosis. The tumor microenvironment (TME) of PC is complex and heterogeneous. Various cellular components in the microenvironment are capable of secreting different active substances that are involved in promoting tumor development. Their release may occur via exosomes, the most abundant extracellular vesicles (EVs), that can carry numerous factors as well as act as a mean of intercellular communication. Emerging evidence suggests that miRNAs are involved in the regulation and control of many pathological and physiological processes. They can also be transported by exosomes from donor cells to recipient cells, thereby regulating the TME. Exosomal miRNAs show promise for use as future targets for PC diagnosis and prognosis, which may reveal new treatment strategies for PC. In this paper, we review the important role of exosomal miRNAs in mediating cellular communication in the TME of PC as well as their potential use in clinical applications.
    MeSH term(s) Humans ; MicroRNAs/genetics ; Pancreatic Neoplasms/genetics ; Pancreatic Neoplasms/pathology ; Exosomes/genetics ; Exosomes/pathology ; Extracellular Vesicles/pathology ; Tumor Microenvironment ; Pancreatic Neoplasms
    Chemical Substances MicroRNAs
    Language English
    Publishing date 2023-04-20
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 80228-1
    ISSN 1873-3492 ; 0009-8981
    ISSN (online) 1873-3492
    ISSN 0009-8981
    DOI 10.1016/j.cca.2023.117360
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Diagnostic value of serum sphingolipids in patients with colorectal cancer.

    Pan, Ziyue / Hu, Zuojian / Guan, Li / Zhang, Lei / Gao, Xia / Yang, Lujie / Gong, Tianqi / Hu, Yanling / Zhao, Yanping / Yu, Hongxiu

    The Analyst

    2022  Volume 147, Issue 10, Page(s) 2189–2197

    Abstract: ... ...

    Abstract Background
    MeSH term(s) Biomarkers ; Biomarkers, Tumor ; Chromatography, Liquid ; Colorectal Neoplasms/diagnosis ; Humans ; Mass Spectrometry ; ROC Curve ; Sphingolipids
    Chemical Substances Biomarkers ; Biomarkers, Tumor ; Sphingolipids
    Language English
    Publishing date 2022-05-17
    Publishing country England
    Document type Journal Article
    ZDB-ID 210747-8
    ISSN 1364-5528 ; 0003-2654
    ISSN (online) 1364-5528
    ISSN 0003-2654
    DOI 10.1039/d1an02239c
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Communication of Survival Data in US Food and Drug Administration-Approved Labeling of Cancer Drugs.

    Naci, Huseyin / Guan, Xiaodong / Woloshin, Steven / Xu, Ziyue / Wagner, Anita K

    JAMA internal medicine

    2021  Volume 181, Issue 11, Page(s) 1521–1522

    MeSH term(s) Access to Information ; Antineoplastic Agents/pharmacology ; Data Display ; Drug Approval/methods ; Drug Labeling/methods ; Drug Labeling/standards ; Humans ; Neoplasms/drug therapy ; Neoplasms/mortality ; Research Design/standards ; Survival Analysis ; United States ; United States Food and Drug Administration
    Chemical Substances Antineoplastic Agents
    Language English
    Publishing date 2021-07-12
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2699338-7
    ISSN 2168-6114 ; 2168-6106
    ISSN (online) 2168-6114
    ISSN 2168-6106
    DOI 10.1001/jamainternmed.2021.3505
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Differences of healthcare utilization and cost between cancer inpatients with and without depression: Based on national health insurance database.

    Bai, Lin / Huang, Cong / Xu, Ziyue / Huang, Tao / Guan, Xiaodong / Shi, Luwen

    Psycho-oncology

    2021  Volume 30, Issue 6, Page(s) 979–981

    MeSH term(s) China ; Depression/epidemiology ; Humans ; Inpatients ; Insurance, Health ; National Health Programs ; Neoplasms/epidemiology ; Neoplasms/therapy ; Patient Acceptance of Health Care
    Language English
    Publishing date 2021-03-05
    Publishing country England
    Document type Journal Article
    ZDB-ID 1118536-3
    ISSN 1099-1611 ; 1057-9249
    ISSN (online) 1099-1611
    ISSN 1057-9249
    DOI 10.1002/pon.5660
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Simultaneous Quantitation of Anlotinib and Osimertinib by Isotope-Labeled UHPLC-MS/MS in Human Plasma: Application in NSCLC Patients.

    Liu, Yao / Lin, Zhong / Luo, Wenji / Pei, Xiaofeng / She, Ziyue / Sha, Zhou / Guan, Yanping / Ming, Dandan / Liang, Jiabi

    Journal of chromatographic science

    2023  Volume 62, Issue 4, Page(s) 339–346

    Abstract: Anlotinib and osimertinib are a class of tyrosine kinase inhibitors for the treatment of malignant tumor. The combination of anlotinib and osimertinib is currently used for treating non-small cell lung cancer (NSCLC) patients. This study aimed to develop ...

    Abstract Anlotinib and osimertinib are a class of tyrosine kinase inhibitors for the treatment of malignant tumor. The combination of anlotinib and osimertinib is currently used for treating non-small cell lung cancer (NSCLC) patients. This study aimed to develop a simple and rapid isotope-labeled UHPLC-MS/MS method for the simultaneous determination of anlotinib and osimertinib in human plasma. The analytes were extracted by protein precipitation with acetonitrile and were then separated on a Shim-pack GIST C18 column. The detection was performed on Shimadzu 8050 triple quadruple mass spectrometer in the positive electrospray ionization mode with multiple reaction monitoring. The precursor-to-product ion transitions were m/z 408.10→ 339.75, 500.25→ 72.20 and 413.50 → 344.50 for anlotinib, osimertinib and D5-anlotinib, respectively. Validation is based on US Food and Drug Administration guidelines. The linearity ranges were 0.5-100 ng/mL for anlotinib and were 1-500 ng/mL for osimertinib with the correlation coefficients (r  2) ≥ 0.99. Accuracy and precision, matrix effect, extraction recovery and stability of anlotinib and osimertinib were acceptable after validation. The UHPLC-MS/MS method was successfully validated and was applied to monitor the concentration of anlotinib and osimertinib in NSCLC patients.
    MeSH term(s) Humans ; Quinolines/blood ; Quinolines/therapeutic use ; Quinolines/pharmacokinetics ; Tandem Mass Spectrometry/methods ; Chromatography, High Pressure Liquid/methods ; Aniline Compounds/blood ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/blood ; Carcinoma, Non-Small-Cell Lung/chemistry ; Indoles/blood ; Indoles/therapeutic use ; Indoles/pharmacokinetics ; Lung Neoplasms/drug therapy ; Lung Neoplasms/blood ; Acrylamides/blood ; Reproducibility of Results ; Linear Models ; Limit of Detection ; Isotope Labeling/methods ; Pyrimidines
    Chemical Substances Quinolines ; osimertinib (3C06JJ0Z2O) ; anlotinib ; Aniline Compounds ; Indoles ; Acrylamides ; Pyrimidines
    Language English
    Publishing date 2023-04-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80141-0
    ISSN 1945-239X ; 0021-9665
    ISSN (online) 1945-239X
    ISSN 0021-9665
    DOI 10.1093/chromsci/bmad024
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top